Advertisement

Urology

Home Urology
There is no connection between vasectomy and overall risk of prostate cancer or prostate cancer mortality

No Link Found Between Vasectomy, Prostate Cancer Risk

Large study challenges previous research linking the procedure to slightly higher chance of disease
Staff members at nearly one in 10 major U.S. cancer centers -- all of which provide palliative care services -- weren't certain such symptom-management and supportive care was actually available there

Some Cancer Center Staff Uncertain of Services Offered

'Mystery shopper' study shows one in 10 facilities provided misinformation on palliative care services
The average annual premiums for single and family coverage remained stable in 2016

Average Premiums for Health Care Coverage Stable in 2016

Family premium 3 percent higher in 2016 than 2015; no change in share of firms offering health benefits
For hypogonadal men with prostate cancer

Testosterone Seems Safe for Hypogonadal Prostate CA Patients

Testosterone therapy seems oncologically safe after treatment or for those on active surveillance
The tension-free vaginal tape-obturator procedure is usually still effective at 10 years after the procedure

Tension-Free Vaginal Tape-Obturator Has Lasting Benefit

After 10 years, objective and subjective cure rates were 69 and 64 percent, respectively
A new set of recommendations has been developed for conduct and reporting of cost-effectiveness analyses

Recommendations Developed for Cost-Effectiveness Analyses

Concept of reference case, set of standard practices that all analyses should follow is recommended
For certain men

Outlook Good for Localized Prostate CA, Despite Tx Chosen

Survival rates high for active surveillance, radiation, or prostatectomy
Parity is associated with increased fiber length in the more proximal coccygeus and iliococcygeus pelvic floor muscles

Potential Mechanism ID’d for Impact of Parity on Pelvic Floor

Parity tied to increased fiber length in more proximal coccygeus, iliococcygeus pelvic floor muscles
A multifaceted value-driven outcomes tool that identifies variability in costs and outcomes can reduce health care costs

Value-Driven Outcomes Tool Can Cut Health Care Costs

Highest variability in costs identified for post-op infection and sepsis, lowest for organ transplant
New anticancer drugs

New Anticancer Drugs Up Costs and Life Expectancy Considerably

Lifetime costs up $72,000, life expectancy up 13 months with new drug use in breast cancer